\
&
Contact us
\
&
Contact us
The NCP Flanders' team consists of 14 persons.
Feel free to reach out to them directly, or use info@ncpflanders.be when it is not clear whom to contact.
We use a simple colour code for the programme labels throughout the site: green is for Horizon Europe, blue is for Horizon 2020 and purple is for Digital Europe. Yellow is used for NCP Flanders related topics.
You can as well visit the Horizon Europe Horizon 2020, Digital Europe, or Defence pages to browse by programme domain and find the responsible NCPs there for each topic.
NCP Flanders is a cooperation between FWO, the Research Foundation Flanders, and VLAIO, Flanders Innovation & Entrepreneurship.
+32 2 553 02 62
+32 2 550 15 55
+32 2 553 09 84
+32 2 553 13 77
+32 2 550 15 64
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
